Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Advanced stage leiomyosarcoma (LMS) is incurable with current systemic antitumor therapies. Therefore, there is clinical interest in exploring novel therapeutic regimens to treat LMS. We reviewed the medical records of 75 consecutive patients with histologically confirmed metastatic LMS, who had bee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Wang, Zhijie, Shi, Naiyi, Naing, Aung, Janku, Filip, Subbiah, Vivek, Araujo, Dejka M., Patel, Shreyaskumar R., Ludwig, Joseph A., Ramondetta, Lois M., Levenback, Charles F., Ramirez, Pedro T., Piha‐Paul, Sarina A., Hong, David, Karp, Daniel D., Tsimberidou, Apostolia M., Meric‐Bernstam, Funda, Fu, Siqing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://ncbi.nlm.nih.gov/pubmed/27882721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados